Corium Joins Russell 3000^® Index
MENLO PARK, Calif. , June 26, 2017 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that it has been added to the Russell 3000…